2001 to 2012: After September 11 · Health, Food & Regulators
Purdue Pharma, the FDA's OxyContin Label, DEA Production Quotas, and 806,000 Opioid Deaths
Period covered: 1995 to 2026 · 9 sources
Summary
In 1995 the Food and Drug Administration approved OxyContin with a label saying its slow release was believed to reduce the abuse liability of the drug, a claim the agency later admitted it had no data for. The company pleaded guilty in 2007 to marketing it as less addictive than it was, and again in 2020 to defrauding the government and paying kickbacks. Between 2002 and 2013 the Drug Enforcement Administration raised the amount of oxycodone that could legally be made in the country by more than 400 percent while the deaths rose, and did not cut it until 2017. About 806,000 Americans died of opioid overdoses between 1999 and 2023. In April 2026 a federal judge, sentencing the company, told the victims that their government had failed them.
The opioid epidemic is usually told as the story of a company. It is also the story of three federal agencies: the one that approved the drug, the one that set how much of it could be made, and the one that prosecuted the company twice and let it keep selling.
The label
The Food and Drug Administration approved OxyContin in December 1995. Its active ingredient, oxycodone, had been in use for decades; what was new was a coating that released it over twelve hours. The label the agency approved stated that delayed absorption, as provided by OxyContin tablets, is believed to reduce the abuse liability of a drug. The Government Accountability Office reported in December 2003 that the agency had later concluded it had no data to support that statement. The company built its sales campaign on the sentence. It doubled its sales force, paid bonuses tied to prescriptions, and, by 2001, had the most prescribed brand name narcotic for moderate to severe pain in the country. Reports of abuse and diversion began in 2000.
The first plea
On May 10, 2007 the Purdue Frederick Company pleaded guilty in federal court in Virginia to a felony: misbranding OxyContin with the intent to defraud and mislead. The government's statement of the case was that Purdue fraudulently marketed OxyContin by falsely claiming that it was less addictive, less subject to abuse, and less likely to cause withdrawal symptoms than other pain medications when there was no medical research to support these claims, and that it had trained its sales representatives to say so while its own market research showed the drug's biggest negative was its abuse potential. The company paid $634.5 million. Its president, its chief lawyer, and its former chief medical officer pleaded guilty to misdemeanors and paid $34.5 million among them. None went to prison. The company kept its license, and OxyContin kept selling.
The quota
The Drug Enforcement Administration sets, each year, the total amount of each controlled substance that may be manufactured in the United States. The Justice Department's inspector general reviewed what the agency did with that power and reported in September 2019. The 2013 quota for oxycodone was over 400 percent of the 2002 quota, up from 34,482 kilograms to 153,750. The agency did not significantly reduce it until 2017, when a 25 percent cut was ordered. Over the same years the inspector general found that the agency was slow to respond to the significant increase in the use and diversion of opioids since 2000, as overdose deaths rose an average of 8 percent a year from 1999 to 2013 and then 71 percent a year from 2013 to 2017, and that it cut its use of immediate suspension orders, its strongest tool against distributors, by more than 80 percent between 2010 and 2017, from 38 a year to six.
The second plea
On November 24, 2020 Purdue Pharma pleaded guilty to three felonies: conspiracy to defraud the United States and violate the food and drug law, and two conspiracies to violate the anti kickback statute. It admitted that it had marketed its opioids to more than 100 doctors it had reason to believe were diverting them to abusers, that it had given the DEA misleading information to inflate its manufacturing quota, and that it had paid kickbacks to doctors and to a medical records company to push prescriptions. The penalties totaled $8.3 billion on paper: a $3.544 billion fine, $2 billion in forfeiture, and $2.8 billion in civil claims. The company was in bankruptcy and most of it was never expected to be paid. The Sackler family, which owned the company, settled civil claims for $225 million.
The bankruptcy and the sentence
The bankruptcy plan that lets the Sackler family pay up to $7 billion over fifteen years and give up the company, in exchange for releases from the claims of creditors who choose to accept, was confirmed on November 18, 2025 after the Supreme Court had struck down an earlier version in June 2024 for releasing the family without the creditors' consent. About $7.4 billion goes to the states, local governments, and an $865 million fund for individuals. On April 29, 2026 a federal judge sentenced the company on its 2020 plea to $5.5 billion in fines and penalties, of which the government will actually collect $225 million, with the rest left for the creditors. Her words to the people in the courtroom were that their government had failed them, and that the inadequacy of what the law can offer had to be plainly stated.
The Official Count
The Centers for Disease Control and Prevention counts the epidemic in three waves: prescription opioids from the 1990s, heroin from 2010, and illegally made fentanyl from 2013. Its figure is that from 1999 to 2023 approximately 806,000 people died from an opioid overdose. Drug overdose deaths of all kinds were 105,007 in 2023, fell to 79,384 in 2024, and by the provisional count released May 13, 2026 fell again to about 69,973 in 2025. The decline is real. It began twenty eight years after the label was approved.
Primary Sources (9)
Documents, court filings, official reports, and broadcasts cited in this report.
Documented Records (3)
Chronological entries extracted from the primary sources above.
Timeline Events (6)
Dated events from this investigation in the site timeline.
More in Health, Food & Regulators
View all stories in Health, Food & Regulators → · Topic overview →
- 2017 to 2026COVID-19 Hospital Payment Bonuses, Remdesivir Approval, PREP Act Hospital Immunity, and Pre-2020 Pandemic PlansIn 2020 Congress paid hospitals 20 percent more for every Medicare patient with a COVID-19 diagnosis and then added a bonus for new treatments, the Food and Drug Administration approved remdesivir seven days after the World Health Organization's own trial found it had little or no effect on death, the government told the public not to take ivermectin in words a federal appeals court later said it had no authority to use, and the March 2020 declaration that gave drugmakers immunity was read by a state supreme court in 2026 to shield a hospital from a patient's death. The plans written before the pandemic had said not to do most of what was done: the government's 2017 guidance said an exposed household in a severe pandemic should stay home for up to three days, and the WHO's 2019 guidance said quarantine of the exposed and contact tracing were not recommended in any circumstances. At a Senate roundtable on September 28, 2026, patients, relatives, nurses, and doctors described what they say was done to patients in hospitals; no hospital or health agency took part, and the senator's office has released no report on it.Health, Food & Regulators
- 2007 to 2026The August 2026 Tariff Waiver for 660 Million Pounds of Foreign Beef Six Days After JBS Met the PresidentOn August 26, 2026 the President signed a proclamation letting 300,000 metric tons of foreign lean beef trimmings, about 660 million pounds, into the country over three months at the low in-quota tariff instead of the 26.4 percent rate that applies above the quota, on the stated ground that ground beef had become too expensive. The Wall Street Journal reported that six days earlier the co-owner of JBS, Joesley Batista, had met the President in the Oval Office and argued for exactly that; the announcement came the next day, and the White House said the decision "was not done as the result of any one conversation." JBS is the Brazilian company whose owners pleaded guilty in the United States in 2020 to bribery, admitted in Brazil to paying nearly 1,900 politicians, and bought their American packing plants with money from a Brazilian state bank. In 2017 the Agriculture Department had halted fresh Brazilian beef after refusing 11 percent of it at the border against 1 percent for the rest of the world. Since 2015 beef in the store has not had to say what country it came from. The week the quota opened, Europe stopped taking Brazilian beef over antibiotic use, the American cattle herd stood at its smallest since 1951, cattle prices fell, and the retail price of ground beef was $6.92 a pound.Health, Food & Regulators
- 1984 to 2026Anthony Fauci's Record: Private Mask Emails, Wuhan Lab Grants, Preemptive Pardon, and Pleadings of the FifthAnthony Fauci ran the National Institute of Allergy and Infectious Diseases for 38 years, was the highest paid employee of the federal government, and in 2020 became the government's voice on the pandemic. The government's own documents record: the email in which he told a cabinet secretary that masks are not really effective and that he did not recommend one, a month before he said the same on television and four months before he explained the advice had been about preserving supply; the herd immunity number he said he nudged up as the polls moved; the six-foot rule that, in his words to Congress, sort of just appeared; the Senate testimony that NIH had not funded a kind of research in Wuhan, and the NIH letter five months later describing an experiment there that EcoHealth failed to report; the audit, the suspension, and the debarment of the grantee; the pardon covering January 2014 to January 2025; the emails in which he wrote please delete this e-mail after you read it; and the day in July 2026 when, under subpoena, he invoked the Fifth Amendment more than a hundred times, after which a Senate committee voted to hold him in contempt.Health, Food & Regulators
- 2021 to 2026The 2026 Health Insurance Premium Spike After ACA Tax Credits ExpiredThe larger premium credits that had made insurance on the exchanges affordable since 2021 expired on December 31, 2025. Congress shut the government for 43 days over them in the fall, took a Senate vote that failed, passed a three year extension in the House in January by 230 to 196, and let it die. Enrollment fell from 22.1 million to 19.2 million, premium payments rose 58 percent for the people who stayed, deductibles rose $1,000, and the budget office expects more than 4 million more people uninsured by 2034, on top of the 10 million from the July 2025 law.Health, Food & Regulators
- 2018 to 2026Boeing 737 MAX Crashes: How the FAA Let Boeing Certify Its Own Planes and the DOJ Dropped Criminal ChargesTwo new Boeing 737 MAX jets crashed in October 2018 and March 2019, killing 346 people, because of a flight control system the company had not fully disclosed to the regulator, the airlines, or the pilots. A congressional investigation found a horrific culmination of faulty assumptions, a lack of transparency, and grossly insufficient oversight by the FAA, which had delegated much of the plane's certification to Boeing's own employees. The Justice Department charged the company with fraud and let it defer prosecution for $2.5 billion. Boeing broke the agreement, a door blew off another MAX in 2024, and in 2025 the government dropped the charge for $1.1 billion. A federal judge said the deal failed to secure the necessary accountability, and that he could not stop it.Health, Food & Regulators